SKYE BIOSCIENCE INC (SKYE) Stock Balance Sheet
NASDAQ:SKYE - Nasdaq - US83086J2006 - Common Stock - Currency: USD
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 3.06M | 2.00M | 172.40K | 1.24M | 8.98M | |||
| Cash Equivalents | 46.42M | 68.42M | 1.26M | N/A | N/A | |||
| Marketable Securities | 12.80M | N/A | N/A | N/A | N/A | |||
| Receivables | 6.40K | 5.10K | 32.50K | N/A | N/A | |||
| Other Current Assets | 735.80K | 409.20K | 10.19M | 7.70M | 630.00K | |||
| Total Current Assets | 63.03M | 70.83M | 11.65M | 8.94M | 9.61M | |||
| Non-Current Assets | ||||||||
| PPE Net | 1.71M | 1.88M | 281.30K | 160.00K | 230.00K | |||
| Other Non-Current Assets | 53.90K | 53.90K | 8.30K | 10.00K | 10.00K | |||
| Total Non-Current Assets | 1.77M | 1.94M | 289.60K | 170.00K | 250.00K | |||
| TOTAL ASSETS | 64.79M | 72.76M | 11.94M | 9.11M | 9.86M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 4.37M | 60.00K | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | 0.00 | 1.85M | 1.97M | |||
| Accrued Expenses | 1.58M | 1.84M | 2.07M | 2.12M | 980.00K | |||
| Accounts Payable | 1.71M | 569.30K | 1.16M | 1.79M | 900.00K | |||
| Other Current Liabilities | 2.03M | 1.93M | 6.30M | 6.30M | 60.00K | |||
| Total Current Liabilities | 5.32M | 4.34M | 13.90M | 12.12M | 3.91M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 223.50K | 273.20K | 171.20K | 0.00 | 80.00K | |||
| Total Non-Current Liabilities | 223.40K | 273.20K | 171.20K | 0.00 | 80.00K | |||
| TOTAL LIABILITIES | 5.54M | 4.61M | 14.07M | 12.12M | 3.99M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -142.05M | -130.95M | -104.38M | -66.74M | -47.26M | |||
| Additional Paid In Capital | 201.27M | 199.07M | 102.24M | 62.82M | 52.64M | |||
| Common Shares | 31.00K | 31.00K | 12.40K | 910.00K | 480.00K | |||
| Shares Outstanding | 30.97M | 30.97M | 12.35M | 3.65M | 1.90M | |||
| Tangible Book Value per Share | 1.91 | 2.20 | -0.17 | -0.82 | 3.08 | |||
| Total Shareholders' Equity | 59.25M | 68.15M | -2.13M | -3.01M | 5.86M | |||
| TOTAL LIABILITIES AND EQUITY | 64.79M | 72.76M | 11.94M | 9.11M | 9.86M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 11.85 | 16.32 | 0.84 | 0.74 | 2.46 | |||
| Return On Assets (ROA) | -50.39% | -36.51% | -315.27% | -213.83% | -86.41% | |||
| Return On Equity (ROE) | -55.11% | -38.98% | N/A | N/A | -145.39% | |||
All data in USD , ROIC based on taxRate of 0.21